- Home
- Industry Reports
- Diagnostics
- Healthcare
- North America Breast Cancer Screening Test Market – Size, Outlook, Trends, and Forecast (2024 – 2032)
Breast cancer screening is to detect cancer in its initial stages. Breast cancer is the one which is out of control growth of cells in the breast. This forms tumours and lumps which can be readily detectable through x-ray. Breast cancer is the one which is the primary cause of mortality among women. Regarding breast cancer screening countries like United States, China, Japan, Germany and United Kingdom constitutes the 60% of the maximum share of breast cancer screening test market.
North America Breast Cancer Screening Test Market Segments size & growth:
The market is valued at USD XX billion in 2017 and is estimated to be USD XX billion by 2024 at a CAGR of XX%. The factors responsible for market growth are mainly due to rise in the incidence of breast cancer, government initiatives for cancer screening programs, awareness among people regarding the screening tests and advancements in breast imaging technologies and adopting highly effective screening test processes.
North America Breast Cancer Screening Test Market Segments share:
The breast cancer screening test market is segmented between tests and end user. By criteria, it is categorised into blood marker tests, imaging tests, genetic tests, and immunohistochemistry. By the end user, it is classified into hospitals, diagnostic centers, cancer industries and research laboratories. In these imaging tests is most commonly used in testing. In imaging test process mammography is the most common screening test and is having the significant market share. Geographically, 60% of the global market share is by North America and 70% of women in the US undergo mammography. North America is holding the most significant market share followed by Europe due to advanced and technological developments and early screening procedures.
North America Breast Cancer Screening Test Market Trends:
- Agendia, the MD Anderson cancer centre and Netherlands cancer institute partners to integrate technologies and data to improve diagnostics and treatment options for colorectal cancer.
- Armune bioscience involved in research and development of a diagnostic and prognostic test for prostate, lung and breast cancer which allow physicians to make more personalised and advanced treatment decisions for better prognosis.
North America Breast Cancer Screening Test Market Research Reports Include:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary market players are:
- A&G Pharmaceutical, Inc.
- Armune Bioscience, Inc.
- Genomic Health, Inc.
- Agendia BV
- BioMark Technologies Inc.
1. Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. The scope of the Study
2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Analytics Tools & Model
2.4. Economic Indicators
2.4.1.Base Year, Base Currency & Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
3. Market Analysis
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of Substitutes
3.2.4 Threat of New Entrants
3.2.5 Industry Rivalry (Competitive Environment)
3.3. PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4. SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.4.5 Y-O-Y Analysis
4. Market Dynamics
4.1. Drivers
4.1.1 Adoption of highly effective methods for screening test processes.
4.1.2 Increasing awareness among the people and consumers.
4.1.3 Increase in pipeline breast cancer screening tests.
4.2. Restraints
4.2.1 Higher screening test process.
4.2.2 Economic uncertainty and reimbursement issues.
4.3. Opportunities
4.3.1 Newer technological developments and approaches.
4.4. Challenges
4.4.1. Innovative medicines and new mechanisms of action to enhance the enthusiasm about major approaches in cancer treatments.
5. North America Breast Cancer Screening Test Market – By Tests
5.1 Introduction
5.2 Blood marker tests
5.3 Imaging tests
5.3.1 Mammograms
5.3.2 MRI
5.3.3 Ultrasound
5.3.4 Mamma print test
5.4 Genetic tests
5.4.1 Fluorescence in-situ hybridisation
5.4.2 HER gene test
5.5 Immunohistochemistry
6. North America Breast Cancer Screening Test Market – By End-user
6.1 Introduction
6.2 Hospitals
6.3 Diagnostics centres
6.4 Cancer institutes
6.5 Research laboratories
7. North America Breast Cancer Screening Test Market – By Country
7.1 North America
7.1.1 Introduction
7.1.2 Middle East
7.1.3 Africa
8. North America Breast Cancer Screening Test Market – Company Profiles
8.1 GE healthcare
8.2 Siemens healthcare
8.3 Cardinal health care
8.4 Nordion Inc.
8.5 Triad isotope
8.6 Eczacibasi Monrol nuclear products
8.7 Mallinckrodt Plc
8.8 Bracco imaging S.p.A
8.9 Advanced accelerator applications SA
8.10 Lantheus medical imaging Inc.
8.11 IBA molecular imaging
8.12 Bayer healthcare
8.13 Siemens healthcare
9. North America Breast Cancer Screening Market – Competitive Landscape
9.1. Market Share Analysis
9.2. Strategies Adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
10. Market Insights
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
11. Appendix
11.1. List of tables
11.2. List of figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €2,016.05 - €6,720.18
- INR: ₹180,072.11 - ₹600,240.36
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,726.61 - £5,755.36
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Breast cancer screening is to detect cancer in its initial stages. Breast cancer is the one which is out of control growth of cells in the breast. This forms tumours and lumps which can be readily detectable through x-ray. Breast cancer is the one which is the primary cause of mortality among women. Regarding breast cancer screening countries like United States, China, Japan, Germany and United Kingdom constitutes the 60% of the maximum share of breast cancer screening test market.
North America Breast Cancer Screening Test Market Segments size & growth:
The market is valued at USD XX billion in 2017 and is estimated to be USD XX billion by 2024 at a CAGR of XX%. The factors responsible for market growth are mainly due to rise in the incidence of breast cancer, government initiatives for cancer screening programs, awareness among people regarding the screening tests and advancements in breast imaging technologies and adopting highly effective screening test processes.
North America Breast Cancer Screening Test Market Segments share:
The breast cancer screening test market is segmented between tests and end user. By criteria, it is categorised into blood marker tests, imaging tests, genetic tests, and immunohistochemistry. By the end user, it is classified into hospitals, diagnostic centers, cancer industries and research laboratories. In these imaging tests is most commonly used in testing. In imaging test process mammography is the most common screening test and is having the significant market share. Geographically, 60% of the global market share is by North America and 70% of women in the US undergo mammography. North America is holding the most significant market share followed by Europe due to advanced and technological developments and early screening procedures.
North America Breast Cancer Screening Test Market Trends:
- Agendia, the MD Anderson cancer centre and Netherlands cancer institute partners to integrate technologies and data to improve diagnostics and treatment options for colorectal cancer.
- Armune bioscience involved in research and development of a diagnostic and prognostic test for prostate, lung and breast cancer which allow physicians to make more personalised and advanced treatment decisions for better prognosis.
North America Breast Cancer Screening Test Market Research Reports Include:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary market players are:
- A&G Pharmaceutical, Inc.
- Armune Bioscience, Inc.
- Genomic Health, Inc.
- Agendia BV
- BioMark Technologies Inc.
1. Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. The scope of the Study
2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Analytics Tools & Model
2.4. Economic Indicators
2.4.1.Base Year, Base Currency & Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
3. Market Analysis
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of Substitutes
3.2.4 Threat of New Entrants
3.2.5 Industry Rivalry (Competitive Environment)
3.3. PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4. SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.4.5 Y-O-Y Analysis
4. Market Dynamics
4.1. Drivers
4.1.1 Adoption of highly effective methods for screening test processes.
4.1.2 Increasing awareness among the people and consumers.
4.1.3 Increase in pipeline breast cancer screening tests.
4.2. Restraints
4.2.1 Higher screening test process.
4.2.2 Economic uncertainty and reimbursement issues.
4.3. Opportunities
4.3.1 Newer technological developments and approaches.
4.4. Challenges
4.4.1. Innovative medicines and new mechanisms of action to enhance the enthusiasm about major approaches in cancer treatments.
5. North America Breast Cancer Screening Test Market – By Tests
5.1 Introduction
5.2 Blood marker tests
5.3 Imaging tests
5.3.1 Mammograms
5.3.2 MRI
5.3.3 Ultrasound
5.3.4 Mamma print test
5.4 Genetic tests
5.4.1 Fluorescence in-situ hybridisation
5.4.2 HER gene test
5.5 Immunohistochemistry
6. North America Breast Cancer Screening Test Market – By End-user
6.1 Introduction
6.2 Hospitals
6.3 Diagnostics centres
6.4 Cancer institutes
6.5 Research laboratories
7. North America Breast Cancer Screening Test Market – By Country
7.1 North America
7.1.1 Introduction
7.1.2 Middle East
7.1.3 Africa
8. North America Breast Cancer Screening Test Market – Company Profiles
8.1 GE healthcare
8.2 Siemens healthcare
8.3 Cardinal health care
8.4 Nordion Inc.
8.5 Triad isotope
8.6 Eczacibasi Monrol nuclear products
8.7 Mallinckrodt Plc
8.8 Bracco imaging S.p.A
8.9 Advanced accelerator applications SA
8.10 Lantheus medical imaging Inc.
8.11 IBA molecular imaging
8.12 Bayer healthcare
8.13 Siemens healthcare
9. North America Breast Cancer Screening Market – Competitive Landscape
9.1. Market Share Analysis
9.2. Strategies Adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
10. Market Insights
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
11. Appendix
11.1. List of tables
11.2. List of figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.